Related Experiment Video
Updated: May 7, 2026

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
Published on: June 28, 2024
Neural tube defects, folic acid and methylation
Apolline Imbard1, Jean-François Benoist, Henk J Blom
1Biochemistry-Hormonology Laboratory, Robert Debré Hospital, APHP, 48 bd Serrurier, Paris 75019, France. apolline.imbard@rdb.aphp.fr.
Abstract:
Neural tube defects (NTDs) are common complex congenital malformations resulting from failure of the neural tube closure during embryogenesis. It is established that folic acid supplementation decreases the prevalence of NTDs, which has led to national public health policies regarding folic acid. To date, animal studies have not provided sufficient information to establish the metabolic and/or genomic mechanism(s) underlying human folic acid responsiveness in NTDs. However, several lines of evidence suggest that not only folates but also choline, B12 and methylation metabolisms are involved in NTDs. Decreased B12 vitamin and increased total choline or homocysteine in maternal blood have been shown to be associated with increased NTDs risk. Several polymorphisms of genes involved in these pathways have also been implicated in risk of development of NTDs. This raises the question whether supplementation with B12 vitamin, betaine or other methylation donors in addition to folic acid periconceptional supplementation will further reduce NTD risk. The objective of this article is to review the role of methylation metabolism in the onset of neural tube defects.
Insights
Neural tube defects (NTDs) are linked to folate, B12, and choline metabolism. Supplementing with B12 and other methyl donors alongside folic acid may further reduce NTD risk.
Area of Science:
- Developmental Biology
- Nutritional Science
- Genetics
Background:
- Neural tube defects (NTDs) are common congenital malformations.
- Folic acid supplementation reduces NTD prevalence, influencing public health policy.
- Mechanisms of human folic acid response in NTDs remain unclear from animal studies.
Purpose of the Study:
- To review the role of methylation metabolism in neural tube defect (NTD) onset.
- To explore the involvement of folate, B12, and choline pathways in NTDs.
- To investigate potential benefits of additional methylation donor supplementation.
Main Methods:
- Literature review of studies on NTDs, folate, B12, choline, and methylation metabolism.
- Analysis of evidence linking maternal blood levels of B12, choline, and homocysteine to NTD risk.
- Examination of genetic polymorphisms in methylation pathways associated with NTDs.
Main Results:
- Evidence suggests B12, choline, and methylation pathways are involved in NTDs.
- Decreased maternal B12 and increased choline or homocysteine are associated with higher NTD risk.
- Gene polymorphisms in these pathways are implicated in NTD development.
Conclusions:
- Methylation metabolism plays a significant role in NTD etiology.
- Periconceptional supplementation with B12 vitamin, betaine, or other methyl donors may offer additional NTD risk reduction.
- Further research is warranted to confirm the efficacy of combined supplementation strategies.
Related Concept Videos
Teratogenicity
Neurulation
Biosynthesis of Nucleic Acids
Vitamins
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life

